CA2802971A1 - New medium, devices and methods - Google Patents

New medium, devices and methods Download PDF

Info

Publication number
CA2802971A1
CA2802971A1 CA2802971A CA2802971A CA2802971A1 CA 2802971 A1 CA2802971 A1 CA 2802971A1 CA 2802971 A CA2802971 A CA 2802971A CA 2802971 A CA2802971 A CA 2802971A CA 2802971 A1 CA2802971 A1 CA 2802971A1
Authority
CA
Canada
Prior art keywords
seq
molecular weight
low molecular
megalin
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2802971A
Other languages
English (en)
French (fr)
Inventor
Jonas Axelsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JJK MEDICAL Ltd
Original Assignee
JJK MEDICAL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JJK MEDICAL Ltd filed Critical JJK MEDICAL Ltd
Publication of CA2802971A1 publication Critical patent/CA2802971A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403—Regulation parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
CA2802971A 2010-06-22 2011-06-17 New medium, devices and methods Abandoned CA2802971A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35723110P 2010-06-22 2010-06-22
EP10166799 2010-06-22
EP10166799.6 2010-06-22
US61/357,231 2010-06-22
PCT/EP2011/060130 WO2011161017A1 (en) 2010-06-22 2011-06-17 New medium, devices and methods

Publications (1)

Publication Number Publication Date
CA2802971A1 true CA2802971A1 (en) 2011-12-29

Family

ID=42989310

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2802971A Abandoned CA2802971A1 (en) 2010-06-22 2011-06-17 New medium, devices and methods

Country Status (10)

Country Link
US (1) US20130098834A1 (cg-RX-API-DMAC7.html)
EP (1) EP2585489A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013532031A (cg-RX-API-DMAC7.html)
CN (1) CN103025762A (cg-RX-API-DMAC7.html)
AU (1) AU2011269156A1 (cg-RX-API-DMAC7.html)
CA (1) CA2802971A1 (cg-RX-API-DMAC7.html)
MX (1) MX2012015253A (cg-RX-API-DMAC7.html)
NZ (1) NZ604034A (cg-RX-API-DMAC7.html)
RU (1) RU2012155121A (cg-RX-API-DMAC7.html)
WO (1) WO2011161017A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3102224B1 (en) * 2013-12-20 2019-02-20 NephroGenesis, LLC. Apparatuses for kidney dialysis and lipocalin protein for use in the prevention or treatment of uremia by dialysis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7498994A (en) * 1993-08-10 1995-02-28 Ao Forschungsinstitut Davos Treatment of tumors by selective protein depletion
JPH09266948A (ja) * 1996-01-31 1997-10-14 Kanegafuchi Chem Ind Co Ltd 血液浄化器および血液浄化装置
AU2462399A (en) 1998-01-22 1999-08-09 Institut National De La Sante Et De La Recherche Medicale Cubilin protein, dna sequences encoding cubilin and uses thereof
US6992171B2 (en) * 2000-06-22 2006-01-31 Takeda Pharmaceutical Company Limited Polypeptide and its DNA
US20040235161A1 (en) 2001-05-17 2004-11-25 Yasuhiko Tabata Artificial kidney having function of metabolizing protein and method of constructing the same
WO2002099438A2 (en) * 2001-06-07 2002-12-12 Max-Delbrueck-Centrum Für Molekulare Medizin Modulation of steroid hormone uptake
AU2002307802A1 (en) * 2002-04-25 2003-10-08 Recepticon Aps Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents
WO2003102593A1 (en) 2002-05-31 2003-12-11 Pfizer Products Inc. Methods for avoiding renal injury
EP1583770A4 (en) * 2002-12-20 2006-10-18 Applera Corp STENOSIS-ASSOCIATED GENETIC POLYMORPHIA, DETECTION METHOD AND ITS USE
US20090110720A1 (en) * 2004-10-06 2009-04-30 Anders Nykjaer Use of compounds for the prevention of drug-induced cell toxicity

Also Published As

Publication number Publication date
EP2585489A1 (en) 2013-05-01
WO2011161017A1 (en) 2011-12-29
NZ604034A (en) 2014-07-25
MX2012015253A (es) 2013-10-01
US20130098834A1 (en) 2013-04-25
AU2011269156A1 (en) 2013-01-10
RU2012155121A (ru) 2014-07-27
JP2013532031A (ja) 2013-08-15
CN103025762A (zh) 2013-04-03

Similar Documents

Publication Publication Date Title
JP2962731B2 (ja) 超純枠半合成代用血液
Buttenschoen et al. Endotoxin elimination in sepsis: physiology and therapeutic application
US11529445B2 (en) Methods and apparatus for kidney dialysis and extracorporeal detoxification
WO2001018060A1 (fr) Materiaux de circulation extracorporelle, adsorbants de facteurs de complication diabetique, reservoirs servant a eliminer des facteurs de complication diabetique et procede d'elimination de facteurs de complication diabetique
JP2006505385A (ja) ポリマーアフィニティーマトリックス、その製造方法、及びその使用
CN113543821B (zh) 包含碱性磷酸酶的血液处理装置
Nisbeth et al. Endotoxemia in chronic renal failure
EP2036584A1 (en) Substrate for biological fluid treatment
JP2015515491A (ja) β−アミロイドの体外的減少のための新規組成物及びその製造方法
US20130098834A1 (en) Medium, devices and methods
JP2004057536A (ja) 変性物質吸着材、変性物質除去カラムおよびそれらを用いた変性物質の除去方法
JP2004236792A (ja) 糖尿病合併症因子吸着体
EP2753425B1 (en) Use of modified hollow fiber materials for removing exotoxins produced by escherichia coli from blood and plasma
JP6857957B2 (ja) 腎臓透析および体外解毒に関する方法および装置
JP2004236791A (ja) 糖尿病合併症因子吸着体
JP2021013846A (ja) 腎臓透析および体外解毒に関する方法および装置
WO2024258949A2 (en) Immunosorbent nanoparticles and methods of using thereof
EP2696895A1 (en) IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
JP2003238404A (ja) 再生可能な糖尿病合併症因子吸着体
AU2015203537B2 (en) Methods and apparatus for kidney dialysis and extracorporeal detoxification
CA2895721C (en) Methods and apparatus for kidney dialysis and extracorporeal detoxification
Cocchi et al. Transport phenomena in dialysis processes
EP3017835B1 (en) Methods and apparatus for kidney dialysis and extracorporeal detoxification
JP2004321682A (ja) 血液浄化用吸着材及びそれを用いたＩｇＡ腎症治療方法
CN110624422A (zh) 一种用于清除羰基化蛋白的透析膜及其制备方法

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20160617